-
1
-
-
84870174908
-
Quality of life of children with type 1 diabetes: A systematic review
-
Nieuwesteeg A, Pouwer F, van der Kamp R, van Bakel H, Aanstoot HJ, Hartman E. Quality of life of children with type 1 diabetes: A systematic review. Curr Diabetes Rev 2012;8:434-443.
-
(2012)
Curr Diabetes Rev
, vol.8
, pp. 434-443
-
-
Nieuwesteeg, A.1
Pouwer, F.2
Van Der Kamp, R.3
Van Bakel, H.4
Aanstoot, H.J.5
Hartman, E.6
-
2
-
-
84892649479
-
Standards of medical care in diabetesd2014
-
American Diabetes Association.
-
American Diabetes Association. Standards of medical care in diabetesd2014. Diabetes Care 2014;37(Suppl. 1):S14-S80.
-
(2014)
Diabetes Care
, vol.37
, pp. S14-S80
-
-
-
3
-
-
0034033028
-
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study group of insulin glargine in type 1 diabetes
-
Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 2000;23:639-643.
-
(2000)
Diabetes Care
, vol.23
, pp. 639-643
-
-
Ratner, R.E.1
Hirsch, I.B.2
Neifing, J.L.3
Garg, S.K.4
Mecca, T.E.5
Wilson, C.A.6
-
4
-
-
0038418746
-
Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart
-
Vague P, Selam JL, Skeie S, et al. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart. Diabetes Care 2003;26:590-596.
-
(2003)
Diabetes Care
, vol.26
, pp. 590-596
-
-
Vague, P.1
Selam, J.L.2
Skeie, S.3
-
5
-
-
84879274635
-
Most youth with type 1 diabetes in the T1D exchange clinic registry do not meet American diabetes association or international society for pediatric and adolescent diabetes clinical guidelines
-
T1D Exchange Clinic Network
-
Wood JR, Miller KM, Maahs DM, et al.; T1D Exchange Clinic Network. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 2013;36:2035-2037.
-
(2013)
Diabetes Care
, vol.36
, pp. 2035-2037
-
-
Wood, J.R.1
Miller, K.M.2
Maahs, D.M.3
-
6
-
-
84866559820
-
Evolution of insulin development: Focus on key parameters
-
Tibaldi JM. Evolution of insulin development: focus on key parameters. Adv Ther 2012;29:590-619.
-
(2012)
Adv Ther
, vol.29
, pp. 590-619
-
-
Tibaldi, J.M.1
-
7
-
-
80054081129
-
Optimizing the replacement of basal insulin in type 1 diabetes mellitus: No longer an elusive goal in the post-NPH era
-
Bolli GB, Andreoli AM, Lucidi P. Optimizing the replacement of basal insulin in type 1 diabetes mellitus: no longer an elusive goal in the post-NPH era. Diabetes Technol Ther 2011;13 (Suppl. 1):S43-S52.
-
(2011)
Diabetes Technol Ther
, vol.13
, pp. S43-S52
-
-
Bolli, G.B.1
Andreoli, A.M.2
Lucidi, P.3
-
8
-
-
84929019522
-
New insulin glargine 300 unitszmL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 unitszmL-1
-
Becker RH, Dahmen R, Bergmann K, Lehmann A, Jax T, Heise T. New insulin glargine 300 unitszmL-1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 unitszmL-1. Diabetes Care 2015;38:637-643.
-
(2015)
Diabetes Care
, vol.38
, pp. 637-643
-
-
Becker, R.H.1
Dahmen, R.2
Bergmann, K.3
Lehmann, A.4
Jax, T.5
Heise, T.6
-
9
-
-
84908179629
-
Newinsulin glargine 300 units/Ml versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: Glucose control and hypoglycemia in a 6-month randomized controlled trial (Edition 1)
-
Home PD; EDITION 1 Study Investigators
-
Riddle MC, Bolli GB, Ziemen M, Muehlen-Bartmer I, Bizet F, Home PD; EDITION 1 Study Investigators. Newinsulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1). Diabetes Care 2014;37:2755-2762.
-
(2014)
Diabetes Care
, vol.37
, pp. 2755-2762
-
-
Riddle, M.C.1
Bolli, G.B.2
Ziemen, M.3
Muehlen-Bartmer, I.4
Bizet, F.5
-
10
-
-
84910033227
-
New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: Glucose control and hypoglycemia in a 6-month randomized controlled trial (Edition 2)
-
EDITION 2 Study Investigators
-
Yki-Järvinen H, Bergenstal R, Ziemen M, et al.; EDITION 2 Study Investigators. New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2). Diabetes Care 2014; 37:3235-3243.
-
(2014)
Diabetes Care
, vol.37
, pp. 3235-3243
-
-
Yki-Järvinen, H.1
Bergenstal, R.2
Ziemen, M.3
-
11
-
-
84922186708
-
New insulin glargine 300 u/mL: Glycemic control and hypoglycemia in Japanese people with T1DM (edition JP 1) (Abstract)
-
EDITION JP1 study group
-
Matsuhisa M, Koyama M, Cheng XN, Shimizu S, Hirose T. EDITION JP1 study group. New insulin glargine 300 U/mL: glycemic control and hypoglycemia in Japanese people with T1DM (EDITION JP 1) (Abstract). Diabetes 2014;63(Suppl. 1A):LB22.
-
(2014)
Diabetes
, vol.63
, pp. LB22
-
-
Matsuhisa, M.1
Koyama, M.2
Cheng, X.N.3
Shimizu, S.4
Hirose, T.5
-
12
-
-
18144388647
-
Defining and reporting hypoglycemia in diabetes: A report from the American diabetes association workgroup on hypoglycemia
-
Workgroup on Hypoglycemia, American Diabetes Association
-
Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005;28:1245-1249.
-
(2005)
Diabetes Care
, vol.28
, pp. 1245-1249
-
-
-
13
-
-
0023942705
-
A measure of treatment satisfaction designed specifically for people with insulin dependent diabetes
-
Lewis KS, Bradley C, Knight G, Boulton AJ, Ward JD. A measure of treatment satisfaction designed specifically for people with insulindependent diabetes. DiabetMed 1988;5:235-242.
-
(1988)
DiabetMed
, vol.5
, pp. 235-242
-
-
Lewis, K.S.1
Bradley, C.2
Knight, G.3
Boulton, A.J.4
Ward, J.D.5
-
14
-
-
0025688231
-
Euroqolda new facility for the measurement of health-related quality of life
-
Euro Qol Group
-
Euro Qol Group. EuroQolda new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
-
(1990)
Health Policy
, vol.16
, pp. 199-208
-
-
-
15
-
-
0000659985
-
The fear of hypoglycemia scale
-
Bradley C, Ed. Hove, Psychology Press
-
Irvine A, Cox DJ, Gonder-Frederick L. The fear of hypoglycemia scale. In Handbook of Psychology and Diabetes: A Guide to Psychological Measurement and Diabetes Research and Practice. Bradley C, Ed. Hove, Psychology Press, 1994, p. 133-155.
-
(1994)
Handbook of Psychology and Diabetes: A Guide to Psychological Measurement and Diabetes Research and Practice
, pp. 133-155
-
-
Irvine, A.1
Cox, D.J.2
Gonder-Frederick, L.3
-
16
-
-
34147116068
-
Optimized use of insulin glargine in intensive treatment of type 1 diabetes mellitus: Benefits and a new question (Abstract)
-
Porcellati F, Rossetti P, Fanelli C, Bolli GB. Optimized use of insulin glargine in intensive treatment of type 1 diabetes mellitus: Benefits and a new question (Abstract). Diabetes 2005; 54:524P.
-
(2005)
Diabetes
, vol.54
, pp. 524
-
-
Porcellati, F.1
Rossetti, P.2
Fanelli, C.3
Bolli, G.B.4
-
17
-
-
84905721701
-
Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml. Diabetes
-
Steinstraesser A, Schmidt R, Bergmann K, Dahmen R, Becker RH. Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml. Diabetes Obes Metab 2014;16:873-876.
-
(2014)
Obes Metab
, vol.16
, pp. 873-876
-
-
Steinstraesser, A.1
Schmidt, R.2
Bergmann, K.3
Dahmen, R.4
Becker, R.H.5
-
18
-
-
84982213135
-
Insulin glargine 300 U/ml vs 100 u/mL: Glucose profiles of morning vs evening injections in adults with type 1 diabetes mellitus measured with continuous glucose monitoring (CGM) (abstract number 949)
-
Bergenstal RM, Bailey TS, Rodbard D, et al. Insulin glargine 300 U/ml vs 100 U/ml: glucose profiles of morning vs evening injections in adults with type 1 diabetes mellitus measured with continuous glucose monitoring (CGM) (Abstract Number 949). Diabetologia 2014;57 (Suppl.):388-389.
-
(2014)
Diabetologia
, vol.57
, pp. 388-389
-
-
Bergenstal, R.M.1
Bailey, T.S.2
Rodbard, D.3
-
19
-
-
84924731879
-
New insulin glargine 300 U/ mL compared with glargine 100 u/ml in insulin-näive people with type 2 diabetes on oral glucose-lowering drugs: Glucose control and hypoglycemia in a randomized controlled trial (EDITION 3)
-
Bolli GB, Riddle MC, Bergenstal R, et al. New insulin glargine 300 U/mL compared with glargine 100 U/mL in insulin-näive people with type 2 diabetes on oral glucose-lowering drugs: glucose control and hypoglycemia in a randomized controlled trial (EDITION 3). Diabetes Obes Metab 2015;17:386-394.
-
(2015)
Diabetes Obes Metab
, vol.17
, pp. 386-394
-
-
Bolli, G.B.1
Riddle, M.C.2
Bergenstal, R.3
-
20
-
-
84907205890
-
Unhelpful information about adverse drug reactions
-
Tan K, Petrie KJ, Faasse K, Bolland MJ, Grey A. Unhelpful information about adverse drug reactions. BMJ 2014;349:g5019.
-
(2014)
BMJ
, vol.349
, pp. g5019
-
-
Tan, K.1
Petrie, K.J.2
Faasse, K.3
Bolland, M.J.4
Grey, A.5
|